Shell plc updated its Q1 FY24 outlook, with lower results expected from its LNG trading business. Integrated Gas and marketing outlooks were also adjusted.
STAAR Surgical reports Q1 2024 net sales surpassing $77 million, with U.S. ICL sales hitting $5 million, the highest since FDA approval in 2022. CEO anticipates fiscal 2024 sales expected at the higher end of $335-340 million outlook.
Alaska Air Group receives $160 million compensation from Boeing in Q1, addressing 737 MAX 9 grounding impact. Additional compensation is expected to be provided beyond first-quarter, the complete terms of which were not disclosed.
FDA grants 510(k) clearance to AngioDynamics' AlphaVac F1885 System for pulmonary embolism. Expanded indication broadens treatment options. Sales slightly below consensus, but pro forma basis sees growth.
Realized Synergies Reduced Cash Burn by 75% vs. Q1/2023 Revenue of $13.2 Million Also Demonstrates Consistent Strong Sales Despite Market Challenges Faced by Other Industry PlayersWaltham, Mass., April 04, 2024